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Antibiotics for operative vaginal delivery: practice-changing 
data
The large randomised controlled trial on the effect of 
antibiotics to prevent infection after operative vaginal 
delivery by Marian Knight and colleagues1 in The Lancet 
is practice changing. Operative vaginal deliveries include 
either vacuum or forceps, and are used in about 2–15% of 
births.2 Even if one conservatively estimates 2% of babies 
are born by operative vaginal delivery globally, about 
2 700 000 of the world’s 135 million annual births are 
operative vaginal deliveries. Up to 16% of these births 
can be associated with infection without antibiotics 
prophylaxis,3 repre senting about 432 000 annual 
infections associated with operative vaginal delivery 
worldwide.
The most common infections increased with operative 
vaginal delivery compared with spontaneous vaginal 
delivery, include endometritis, perineal wound, and 
urinary tract infections—all of which, in rare cases, can lead 
to sepsis.3 Compared with spontaneous vaginal delivery, 
operative vaginal delivery can introduce microorganisms 
into the genital tract, is associated with longer labour, 
more vaginal examinations, with bladder catheterisation 
before the procedure, and with more perineal lacerations 
and use of episiotomy, all of which can increase the risk of 
infections. These infections can occur even after discharge, 
and the risk peaks at about 6–7 days post partum.3 The 
incidence of infections is higher with forceps than with 
vacuum. Episiotomy also increases the risk of perineal 
infections compared with no episiotomy,4 possibly 
also because of the association with more and worse 
perineal lacerations.5 Unfortunately, the evidence on the 
effect of technical characteristics of the repair of perineal 
lacerations or episiotomies, or both, on perineal infections 
is scarce.6,7 Perineal infections are associated with wound 
dehiscence, need for repair, and perineal pain, and 
influence women’s quality of life and sexual wellbeing.3
In Knight and colleagues’ study,1 3427 women with 
mostly singleton gestations at 36 weeks or later were 
randomly assigned to receive either amoxicillin 1 g 
and clavulanic acid 200 mg or placebo within 6 h of 
operative vaginal delivery. The primary outcome, 
confirmed or suspected maternal infection within 
6 weeks of delivery, was defined by one of the following: 
a new prescription of antibiotics for presumed perineal 
wound-related infection, endo metritis or uterine 
infection, urinary tract infection with systemic features 
(pyelonephritis or sepsis), or other systemic infection 
(clinical sepsis); confirmed systemic infection on culture; 
or endometritis. This primary outcome was significantly 
less common in the antibiotic (11%) versus the placebo 
(19%) group (risk ratio [RR] 0·58, 95% CI 0·49–0·69). 
The incidences of perineal infection, perineal pain, 
use of pain relief for perineal pain, need for additional 
perineal care, wound breakdown, perineum ever too 
uncomfortable to feed the baby, and any visits in 
relation to perineal concerns were all each statistically 
significantly decreased in the antibiotics group 
compared with placebo. The primary outcome was 
more common in forceps versus vacuum deliveries, but 
the magnitude of the beneficial effect of the antibiotic 
versus placebo was similar (forceps 13% vs 22%, RR 0·62, 
95% CI 0·45–0·86, respectively; vacuum 8% vs 14%, 
RR 0·56, 95% CI 0·39–0·80, respectively).
The main strengths of this study are that it is large, 
methologically well done, covers an important clinical 
issue, and is practice changing. Only one small study8 had 
been previously done on this issue. Other strengths are 
the use of only one dose of antibiotics, limiting the effect 
on microbiota of both mother and baby (effect through 
breastfeeding). Risks of negative effects on the baby, such 
as necrotising enterocolitis or asthma,3 can be minimised 
if the antibiotic is given after delivery, and this antibiotic 
has been shown to be safe for infant breastfeeding.9
The main limitation of the study is the primary 
outcome, which was driven mostly by a new prescription 
for antibiotics for presumed perineal infection. Although 
the trial was blinded, the prescribing of antibiotics is 
more subjective than culture-proven infection. The 
study shows that the results for the cumulative primary 
outcome are the same as those for new prescription 
for antibiotics for presumed perineal infection. The 
criteria used by practitioners to decide to whom to give 
antibiotics was unclear. Nonetheless, confirmed culture-
proven sepsis was significantly less in the amoxicillin 
and clavulanic acid group than in the placebo group 
(0·6% vs 1·5%, respectively; RR 0·44, 95% CI 0·22–0·89). 
The timing of antibiotics was 3·2 h after delivery, which is 
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Renal cell carcinoma is one of the most common 
urological cancers and its incidence is on the rise.1 
Outcomes for patients with advanced renal cell carcinoma 
have improved substantially with the advent of vascular 
endothelial growth factor (VEGF)-targeted drugs, and 
with the approval of immune checkpoint blocking 
antibodies in the past 4 years.2 Although each of these 
drug classes has shown single drug efficacy, responses 
remain transient for most patients, culminating in a 
high proportion of patients eventually having disease 
progression or death.2
Angiogenesis and immunosuppression are hallmarks 
of cancer that allow for tumour cell growth and 
survival, and preclinical and early phase clinical data 
have shown these two pathways to be linked.3–5 
Targeting VEGF and its receptors results in increased 
T-cell priming and infiltration; however, targeting 
also induces interferon gamma-mediated counter-
regulatory programmed death-ligand 1 (PD-L1) 
upregulation, and T-cell exhaus tion.3,5 Furthermore, 
PD-L1 expression predicts for worse outcomes after 
treatment with antiangiogenic drugs in patients 
with renal cell carcinoma.6,7 Thus, the combination 
of antiangiogenic and immune checkpoint 
blocking drugs, which allows a newly inflamed 
tumour microenvironment to effectively eradicate 
Durable complete response in renal cell carcinoma clinical trials
late; in practice, administration of the antibiotic intrave-
nously right after delivery would be feasible. Indeed, 
prophylaxis for caesarean section is more effective when 
given before skin incision than after cord clamping. 
The choice of antibiotics is debatable, but Knight and 
colleagues have made a good case for their choice of 
amoxicillin and clavulanic acid.3 Another limitation of 
the study is that women with third-degree and fourth-
degree lacerations were excluded because they get 
antibiotics anyway.10 The majority (89%) of women 
enrolled had an episiotomy—a proportion that is too 
high, even for operative vaginal delivery, as admitted 
by authors. Unfortunately, a subgroup analysis for just 
those women without an episiotomy is not available. 
Moreover, neonatal outcomes are not reported; although 
the antibiotic was given after birth, it is secreted in 
breastmilk, and could affect neonates. Another potential 
issue is the development of antibiotic resistance.
More emphasis should be placed on prevention of 
perineal trauma, and therefore perineal infection, in 
future research. The use of perineal massage11 and warm 
compresses to the perineum12 in the second stage of 
labour have each been associated with a significant 
decrease in perineal trauma. Clinical guidelines should 
be updated to reflect the new recommendation of 
giving a single dose of intravenous amoxicillin and 
clavulanic acid within 6 h after operative vaginal 
delivery, in particular to women who also have an 
episiotomy. More research is needed for operative 
vaginal deliveries not necessitating an episiotomy.
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